COMMUNIQUÉS West-GlobeNewswire

Performer 8 Male Enhancement “Launch” The Herbal Performance Enhancer Non Prescription ED Pills for Men 2025 over the counter by Performer 8
14/09/2025
Performer 8 is a non-prescription male enhancement pills, herbal performance enhancer ED pill for men formulated to support natural stamina, libido, testosterone levels, and sexual NEW YORK , Sept. 14, 2025 (GLOBE [...]
TestoPrime Launch: Advanced Testosterone Booster for Men Over 50’ For Muscle Gain | Does TestoPrime Actually Work?
14/09/2025
Clinicians’ Tested Choice Best Testosterone Booster Supplements to increase testosterone and muscle gain for men: Medically Reviewed and Endorsed by Leading FDA Experts, Now Available over the counter Without [...]
Monopar to Present New Long-Term Neurological Efficacy and Safety Data for ALXN1840 in Wilson Disease at the 150th American Neurological Association Annual Meeting
14/09/2025
WILMETTE, Ill., Sept. 14, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company developing innovative treatments for patients with [...]
Fangzhou Unveils “XingShi” LLM to Advance AI-Driven Chronic Disease Management
14/09/2025
SHANGHAI, Sept. 14, 2025 (GLOBE NEWSWIRE) -- At its 10th H2H Healthcare Ecosystem Conference, Fangzhou Inc. (“Fangzhou” or the “Company”) (06086.HK), a leader in AI-driven Internet healthcare solutions, announced the [...]
Hapbee Strengthens Leadership Team with Key Appointments; Provides Update on Shares-for-Debt Settlement
13/09/2025
New leadership roles designed to fast-track Hapbee’s product strategy and accelerate product deployments VANCOUVER, British Columbia, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Hapbee Technologies Inc. (“Hapbee” or the “Company [...]
4DMT Announces New Employment Inducement Grants
12/09/2025
EMERYVILLE, Calif., Sept. 12, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with [...]
Vor Bio to Participate in the Stifel 2025 Virtual Immunology and Inflammation Forum
12/09/2025
CAMBRIDGE, Mass., Sept. 12, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that it will participate in a [...]
Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
12/09/2025
DURHAM, N.C., Sept. 12, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization, today announced the granting of an inducement award of restricted stock units (“ [...]
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12/09/2025
CAMBRIDGE, Mass., Sept. 12, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. ® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with [...]
Avicanna Announces Change in CFO
13/09/2025
TORONTO, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or the “ Company ”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and [...]
Aja Health And Wellness Inc. Provides Update on Delay in Filing Financial Statements
13/09/2025
Not for dissemination in the United States of America VANCOUVER, British Columbia, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Aja Health and Wellness Inc. ("Aja" or the "Company") (TSXV:Aja) announces that it is getting closer [...]
Merit Medical Embosphere Microspheres Achieve CE Mark for Genicular Artery Embolisation to Treat Knee Osteoarthritis
12/09/2025
Expanded indication provides patients with knee osteoarthritis the benefits of Embosphere’s consistent, predictable, and effective clinical results. SOUTH JORDAN, Utah, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Merit Medical [...]
Curanex Pharmaceuticals Inc. Announces Exercise of the Over-Allotment Option by Underwriters
12/09/2025
Jericho, New York, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Curanex Pharmaceuticals Inc. (Nasdaq: CURX) (“Curanex” or the “Company”), a developmental stage pharmaceutical company focused on discovering and developing [...]
Sanofi: Informations relatives au nombre de droits de vote et d'actions - AOUT 2025
12/09/2025
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés Financiers Sanofi Société [...]
Sanofi: Information concerning the total number of voting rights and shares - August 2025
12/09/2025
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’ [...]
INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
12/09/2025
Conformément aux articles L.233-8 II du Code de commerce et 223-16 du Règlement Général de l’Autorité des Marchés Financiers PARIS, 12 sept. 2025 (GLOBE NEWSWIRE) -- Place de cotation : Euronext Paris / Nasdaq Euronext [...]
Voting Rights and Shares Capital of the Company
12/09/2025
In accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers) PARIS, Sept. 12, 2025 (GLOBE NEWSWIRE [...]
HealthLynked Strengthens Intellectual Property Portfolio with New Patent Filings in AI and Patient Record Management
12/09/2025
NAPLES, Fla., Sept. 12, 2025 (GLOBE NEWSWIRE) -- via IBN -- HealthLynked Corp. (OTCQB: HLYK ), a leader in patient-centric healthcare technology, today announced the submission of two new U.S. patent applications, [...]
Olympia Pharmaceuticals Wins Orlando Business Journal’s Family-Owned Business Award
12/09/2025
The state-of-the-art 503B pharmaceutical outsourcing facility and 503A pharmacy has been recognized in the Expansion category for its family legacy amid astonishing growth ORLANDO, Fla., Sept. 12, 2025 (GLOBE NEWSWIRE [...]

Pages